Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Callio Therapeutics Appoints Zachary Hornby As Chief Executive Officer

PRIVATESep 10, 2026•about 2 hours ago

Position

Chief Executive Officer

Company

Callio Therapeutics

Zachary Hornby
SeattleBiotechnologyHealth CareTherapeutics

Description

Callio Therapeutics has appointed Zachary Hornby as Chief Executive Officer, effective immediately. Hornby brings extensive experience in leading biotechnology companies through clinical development and financing.

Company Information

Company

Callio Therapeutics

Location

Seattle, Washington, United States

About

Callio Therapeutics is a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADC) to enhance cancer therapy. The company is developing next-generation multi-payload ADCs with differentiated linking and payload technologies to enable targeted administration of multiple agents to tumor cells to maximize therapeutic benefit.

Don't miss Callio Therapeutics's next move

Get an email the moment Callio Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Jerome
Likely contact at this company
••••••••@••••••••

See Jerome's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Callio Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Callio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.